Detail akcie Thermo Fisher Scientific online

Business Summary: Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offer virtually everything needed for the laboratory. It also provides purification and filtration technologies.
Financial Summary: BRIEF: For the three months ended 28 March 2026, Thermo Fisher Scientific Inc revenues increased 6% to $11.01B. Net income increased 10% to $1.65B. Revenues reflect Laboratory Products and Biopharma Services segment increase of 7% to $6B, Life Sciences Solutions segment increase of 14% to $2.22B, Europe segment increase of 13% to $2.96B, North America segment increase of 3% to $5.71B, Asia Pacific segment increase of 4% to $1.97B.